The uptake of 125I-anti-PRR was higher in Panc-1, ASPC, and Miapaca tumor-bearing mice than in BXPC-3 and HPAC after 96 hours injection (Figure 6A and 6B). Here, ATP6AP2 is linked to neoplasm.